Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Jin Jin, PhD (she/her/hers)

Executive Director and Senior Fellow
Genentech, Inc.
Foster City, California, United States

Jin Y. Jin, PhD, Executive Director and Senior Fellow, Global Head of Modeling and Simulation, and Clin Pharm-Ophtha/Neuro, Clinical Pharmacology, Genentech

Dr. Jin Yan Jin is Executive Director and Senior Fellow in Clinical Pharmacology at Genentech. As Global Head of Modeling and Simulation (M&S), she oversees clinical M&S and data programming for all modalities in all therapeutic areas. As Head of Clin Pharm-Ophthalmology/Neuroscience, she also oversees overall clinical pharmacology strategy in these TAs. Before joining Genentech, she worked at Eli Lilly in metabolism and neuroscience areas after Ph.D. and post-doc in Pharmaceutical Sciences from the State University of New York at Buffalo.

Dr. Jin is recognized for her scientific passion of using wide range of quantitative approaches (pharmacometrics, disease model, model-based meta-analysis, physiologically-based PK, quantitative system pharmacology, machine learning/artificial intelligence) leveraging diverse data sources (clinical, preclinical, literature, real-world data) to impact development of different modalities across therapeutic areas. She has strong scientific presence with 100+ publications, 40+ oral presentations worldwide, invited panelist on diverse topics, and moderated many scientific conferences, workshops and sessions. Dr. Jin is also a strong advocate for Model-Informed Drug Development (MIDD) and a reputable leader in the global scientific community. Her recent society leadership roles include as the President (2018) and Board of Director (2014-19) of ISoP; chair of the 2015 ACoP meeting; co-chair of the 2018 FDA-ISoP MIDD in Oncology Public Workshop under PDUFA VI; member of Editorial Board for CPT:PSP; and member of various committees for ASCPT. She was recognized as ISoP Fellow in 2020 and received the ISoP Leadership award in 2023.

Disclosure(s): Genentech, Inc.: Employment (Ongoing)

Presentation(s):

Email Jin